Division of Polymer Chemistry, Department of Chemistry-Ångström, Sciences Life Laboratory, Uppsala University, Uppsala, Sweden.
PLoS One. 2013 Aug 13;8(8):e71683. doi: 10.1371/journal.pone.0071683. eCollection 2013.
While testing regenerative medicine strategies, the use of animal models that match the research questions and that are related to clinical translation is crucial. During the initial stage of evaluating new strategies for bone repair, the main goal is to state whether the strategies efficiently induce the formation of new bone tissue at an orthotopic site. Here, we present a subperiosteal model in rat calvaria that allow the evaluation of a broad range of approaches including bone augmentation, replacement and regeneration. The model is a fast to perform, minimally invasive, and has clearly defined control groups. The procedure enables to evaluate the outcomes quantitatively using micro-computed tomography and qualitatively by histology and immunohistochemistry. We established this new model, using bone morphogenetic protein-2 as an osteoinductive factor and hyaluronic acid hydrogel as injectable biomaterial. We showed that this subperiosteal cranial model offers a minimally invasive and promising solution for a rapid initial evaluation of injectables for bone repair. We believe that this approach could be a powerful platform for orthopedic research and regenerative medicine.
在测试再生医学策略时,使用与研究问题相匹配且与临床转化相关的动物模型至关重要。在评估骨修复新策略的初始阶段,主要目标是确定这些策略是否能有效地在原位诱导新骨组织的形成。在这里,我们提出了一种在大鼠颅骨骨膜下的模型,该模型允许评估广泛的方法,包括骨增强、替代和再生。该模型操作快速、微创,且具有明确的对照组。该程序可以使用微计算机断层扫描进行定量评估,并通过组织学和免疫组织化学进行定性评估。我们使用骨形态发生蛋白-2 作为成骨诱导因子和透明质酸水凝胶作为可注射生物材料建立了这个新模型。我们表明,这种骨膜下颅模型为快速评估骨修复用注射剂提供了一种微创且有前景的解决方案。我们相信,这种方法可能成为骨科研究和再生医学的强大平台。